Roche’s bispecific antibody, Columvi receives European approval for diffuse large B-cell lymphoma after initial therapy: Basel Tuesday, April 15, 2025, 10:00 Hrs [IST] Roche ann ...

Our Bureau, Mumbai Tuesday, April 15, 2025, 09:00 Hrs [IST] ChemExpo India 2025, a broad-based chemical industry even ...

DHR invites proposals under HRD Scheme for Health Research 2025–26: Shardul Nautiyal, Mumbai Tuesday, April 15, 2025, 08:00 Hrs [IST] The Union Ministry of Health, through its D ...

DGFT launches Global Tariff and Trade helpdesk to boost pharma exports amid global trade shifts: Shardul Nautiyal, Mumbai Tuesday, April 15, 2025, 08:00 Hrs [IST] In a major initi ...

DCA Delhi seizes counterfeit version of topical medication, Thrombophob 20gm: Peethaambaran Kunnathoor, Chennai Tuesday, April 15, 2025, 08:00 Hrs [IST] In a major breakthrough in ...

The Association of Indian Medical Device Industry (AIMED) has urged the government to impose safeguard duties on 12 key medical device categories, warning that uncontrolled imports are putting ...

NPPA issues draft calculation sheet for nine scheduled formulations: Gireesh Babu, New Delhi Tuesday, April 15, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing Authority ...

Halozyme announces US FDA approval of argenx's Vyvgart Hytrulo prefilled syringe co-formulated with ENHANZE for self-injection for gMG and CIDP: San Diego Monday, April 14, 2025, ...

IDEAYA Biosciences begins phase 1/2 clinical trial to evaluate IDE397 and Trodelvy combination in MTAP-deletion urothelial cancer: South San Francisco, California Monday, April 14 ...

Shuttle Pharma seeks US patent for PSMA Ligand Conjugates to treat prostate cancer: Gaithersburg, Maryland Monday, April 14, 2025, 16:00 Hrs [IST] Shuttle Pharmaceuticals Holdings ...

Oculis Holding completes enrollment in both DIAMOND phase 3 clinical trials of OCS-01 in diabetic macular edema: Zug, Switzerland Monday, April 14, 2025, 15:00 Hrs [IST] Oculis Ho ...

Our Bureau, Mumbai Monday, April 14, 2025, 14:40 Hrs [IST] ...